19 June 2013
Keywords: Vivus, Luramist, Acrux, Testosterone for women
Article | 01 April 2010
The USA’s Vivus has terminated the development and commercialization agreement with FemPharm, a wholly-owned subsidiary of Australian drug company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 April 2010
© 2013 thepharmaletter.com